Market Tracker

04/17 5:37am ET

GenMark Diagnostics Inc (NASDAQ:GNMK)

9.42
Data as of Apr 16
 +0.13 / +1.40%
Today’s Change
8.75
Today|||52-Week Range
16.00
-29.12%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close9.29
Today’s open9.38
Day’s range-- - --
Volume126,876
Average volume (3 months)220,271
Market cap$405.7M
Dividend yield--
Data as of 04/16/2014

Growth & Valuation

Earnings growth (last year)-13.10%
Earnings growth (this year)-22.74%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+33.88%
P/E ratioNM
Price/Sales17.10
Price/Book3.68

Competitors

 Today’s
change
Today’s
% change
CTICCell Therapeutics In...-0.06-1.97%
NBSNeoStem Inc+0.23+3.58%
RDNTRadNet Inc0.000.00%
NEONeogenomics Inc-0.04-1.27%
Data as of 04/16/2014

Financials

Next reporting dateMay 6, 2014
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$27.4M
Annual profit (last year)-$33.6M
Net profit margin-122.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Senior VP-Global Operations &
Human Resources
Jennifer Anne Williams
Corporate headquarters
Carlsbad, California

Forecasts